Anna Clara Albuquerque Pataro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Clara Albuquerque Pataro has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Danielle Aparecida Gomes Pereira
Universidade Federal de Minas Gerais
1 shared publication - Deborah dos Reis Estrella
Hospital Felício Rocho, Belo Horizonte, MG, Brasil
1 shared publication - Eliane Viana Mancuzo
Federal University of Minas Gerais, Belo Horizonte, Brazil
1 shared publication - Giane Amorim Ribeiro-Samora
Federal University of Rio Grande do Norte Natal Brazil
1 shared publication - Hugo Leonardo Alves Pereira
Universidade Federal de Minas Gerais
1 shared publication - Verônica Franco Parreira
Department of Physiotherapy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
1 shared publication
Latest Publications
- 11 April 2024
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 41 (3) , 481-489
Concurrent validity between field tests and cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis
Maximal treadmill cardiopulmonary exercise testing is the gold standard for assessing functional capacity in patients with idiopathic pulmonary fibrosis (IPF). Primarily to investigate the concurrent validity between three field tests and cardiopulmonary exercise testing in these patients. Patients performed the cardiopulmonary exercise testing, a six-minute walk test, an incremental shuttle walk test, and, the Glittre-ADL test. For cardiopulmonary exercise testing, the ten seconds with the higher average of the peak oxygen uptake obtained within the last 30 seconds were considered; for six-minute walk test and incremental shuttle walk test, the longer distance; and for the Glittre-ADL test, the shorter time spent. Concurrent validity was assessed using different regression models based on the best adjustment of the data. Twenty-two patients with IPF were assessed, aged: 68 ± 8.1 years, 13 male. Patients presented a peak oxygen uptake of 16.5 ± 3.6 mL.kg-1.min1, achieving a distance of 512.6 ± 102.8 meters in the six-minute walk test and 415.7 ± 125.1 meters in incremental shuttle walk test. The walking distance in the six-minute walk test and the incremental shuttle walk test explained, respectively, 64% and 56% peak oxygen uptake variance observed in the cardiopulmonary exercise testing (R2 = 0.64,p < .001; R2 = 0.56,p < .001). The time spent in the Glittre-ADL test was 233.4 ± 88.7 seconds and explained 47% of the peak oxygen uptake variance observed in cardiopulmonary exercise testing (R2 = 0.47,p = .001). The six-minute walk test, incremental shuttle walk test, and Glittre-ADL test were considered valid tests to explain the peak oxygen uptake variance obtained by the cardiopulmonary exercise testing in patients with IPF.
- 11 April 2024
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 41 (3) , 481-489
Concurrent validity between field tests and cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis
Maximal treadmill cardiopulmonary exercise testing is the gold standard for assessing functional capacity in patients with idiopathic pulmonary fibrosis (IPF). Primarily to investigate the concurrent validity between three field tests and cardiopulmonary exercise testing in these patients. Patients performed the cardiopulmonary exercise testing, a six-minute walk test, an incremental shuttle walk test, and, the Glittre-ADL test. For cardiopulmonary exercise testing, the ten seconds with the higher average of the peak oxygen uptake obtained within the last 30 seconds were considered; for six-minute walk test and incremental shuttle walk test, the longer distance; and for the Glittre-ADL test, the shorter time spent. Concurrent validity was assessed using different regression models based on the best adjustment of the data. Twenty-two patients with IPF were assessed, aged: 68 ± 8.1 years, 13 male. Patients presented a peak oxygen uptake of 16.5 ± 3.6 mL.kg-1.min1, achieving a distance of 512.6 ± 102.8 meters in the six-minute walk test and 415.7 ± 125.1 meters in incremental shuttle walk test. The walking distance in the six-minute walk test and the incremental shuttle walk test explained, respectively, 64% and 56% peak oxygen uptake variance observed in the cardiopulmonary exercise testing (R2 = 0.64,p < .001; R2 = 0.56,p < .001). The time spent in the Glittre-ADL test was 233.4 ± 88.7 seconds and explained 47% of the peak oxygen uptake variance observed in cardiopulmonary exercise testing (R2 = 0.47,p = .001). The six-minute walk test, incremental shuttle walk test, and Glittre-ADL test were considered valid tests to explain the peak oxygen uptake variance obtained by the cardiopulmonary exercise testing in patients with IPF.